Literature

Circulating Tumor Cell-based Molecular Responses Stratify EGFR-TKI Efficacy in Patients with EGFR-Mutant Lung Cancer

Cancer Res Treat. 2026, January 27 [E-pub]. https://doi.org/10.4143/crt.2025.672

Robust Automated Separation of Circulating Tumor Cells and Cancer-Associated Fibroblasts for Enhanced Liquid Biopsy in Breast CancerArticle link copied!

Anal. Chem. 2025, 97, 32, 17452–17461. https://doi.org/10.1021/acs.analchem.5c02154

Cytokine engineered NK-92 therapy to improve persistence and anti-tumor activity

Theranostics 2023; 13(5):1506-1519. doi:10.7150/thno.79942

Cytokine engineered NK-92 therapy to improve persistence and anti-tumor activity

Theranostics 2023; 13(5):1506-1519. doi:10.7150/thno.79942

Lossless Immunocytochemistry Based on Large-Scale Porous Hydrogel Pellicle for Accurate Rare Cell Analysis

ACS Appl. Mater. Interfaces 2023, 15, 12, 15059–15070 doi:10.1021/acsami.2c18321

Continuous centrifugal microfluidics (CCM) isolates heterogeneous circulating tumor cells via full automation

Theranostics 2022; 12(8):3676-3689. doi:10.7150/thno.72511

An electroceutical approach enhances myelination via upregulation of lipid biosynthesis in the dorsal root ganglion

Biofabrication, Volume 14, Number 1, doi:10.1088/1758-5090/ac457c

Development of an antibody-like T-cell engager based on VH-VL heterodimer formation and its application in cancer therapy

Biomaterials Volume 271, doi:10.1016/j.biomaterials.2021.120760

Pipeline

CTCELLS Pipeline Graphic